Edwards Lifesciences's total assets for Q3 2024 were $12.97B, an increase of 28.44% from the previous quarter. EW total liabilities were $3.36B for the fiscal quarter, a 29.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.